# OnCo record hypothyroidism-on-tyrosine-kinase-inhibitors (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/hypothyroidism-on-tyrosine-kinase-inhibitors/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "hypothyroidism-on-tyrosine-kinase-inhibitors" ;
  schema:name "Underactive thyroid on VEGFR-targeted tyrosine kinase inhibitors: thyroid tests and levothyroxine"@en ;
  schema:alternateName "TKI-induced hypothyroidism"@en, "sunitinib hypothyroidism"@en, "axitinib hypothyroidism"@en, "lenvatinib hypothyroidism"@en, "cabozantinib thyroid dysfunction"@en, "pazopanib hypothyroidism"@en, "thyroid monitoring on kinase inhibitors"@en, "TSH monitoring on anti-angiogenic tablets"@en, "levothyroxine on tyrosine kinase inhibitors"@en ;
  schema:description "Many targeted cancer tablets that block blood vessel growth, such as sunitinib, axitinib, lenvatinib and cabozantinib, can make the thyroid underactive. It causes tiredness, feeling cold, constipation and weight gain, which are easy to blame on the cancer. A blood test (TSH) before and during treatment finds it, and a daily levothyroxine tablet treats it. Your own team's plan comes first."@en ;
  schema:url <https://onco.cc/protocols/hypothyroidism-on-tyrosine-kinase-inhibitors/> ;
  schema:dateModified "2026-11-17"^^xsd:date ;
  onco:related <https://onco.cc/protocols/irae-thyroid/>, <https://onco.cc/drugs/levothyroxine/>, <https://onco.cc/protocols/hypertension-and-proteinuria-on-vegf-pathway-inhibitors/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/pazopanib/>, <https://onco.cc/drugs/axitinib/>, <https://onco.cc/drugs/cabozantinib/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/tivozanib/>, <https://onco.cc/drugs/vandetanib/>, <https://onco.cc/drugs/sorafenib/>, <https://onco.cc/drugs/fruquintinib/> .
